Sudenga SL - Search Results

1

Variants in immune-related genes and genital HPV 16 persistence in men.

Mainali B, Schabath MB, Sudenga SL, Ye Y, Wiener HW, Villa LL, Giuliano AR, Shrestha S. Mainali B, et al. Among authors: sudenga sl. Papillomavirus Res. 2019 Jun;7:11-14. doi: 10.1016/j.pvr.2018.08.001. Epub 2018 Aug 6. Papillomavirus Res. 2019. PMID: 30092369 Free PMC article.

2

The impact of highly active antiretroviral therapy on prevalence and incidence of cervical human papillomavirus infections in HIV-positive adolescents.

Shrestha S, Sudenga SL, Smith JS, Bachmann LH, Wilson CM, Kempf MC. Shrestha S, et al. Among authors: sudenga sl. BMC Infect Dis. 2010 Oct 14;10:295. doi: 10.1186/1471-2334-10-295. BMC Infect Dis. 2010. PMID: 20946655 Free PMC article.

3

Transitional probability-based model for HPV clearance in HIV-1-positive adolescent females.

Kravchenko J, Akushevich I, Sudenga SL, Wilson CM, Levitan EB, Shrestha S. Kravchenko J, et al. Among authors: sudenga sl. PLoS One. 2012;7(1):e30736. doi: 10.1371/journal.pone.0030736. Epub 2012 Jan 24. PLoS One. 2012. PMID: 22292027 Free PMC article.

4

Incidence, prevalence, and epidemiology of herpes simplex virus-2 in HIV-1-positive and HIV-1-negative adolescents.

Sudenga SL, Kempf MC, McGwin G Jr, Wilson CM, Hook EW 3rd, Shrestha S. Sudenga SL, et al. Sex Transm Dis. 2012 Apr;39(4):300-5. doi: 10.1097/OLQ.0b013e318244a90f. Sex Transm Dis. 2012. PMID: 22421698 Free PMC article.

5

Key considerations and current perspectives of epidemiological studies on human papillomavirus persistence, the intermediate phenotype to cervical cancer.

Sudenga SL, Shrestha S. Sudenga SL, et al. Int J Infect Dis. 2013 Apr;17(4):e216-20. doi: 10.1016/j.ijid.2012.12.027. Epub 2013 Feb 27. Int J Infect Dis. 2013. PMID: 23453716 Free PMC article.

6

Variants in interleukin family of cytokines genes influence clearance of high risk HPV in HIV-1 coinfected African-American adolescents.

Sudenga SL, Wiener HW, Shendre A, Wilson CM, Tang J, Shrestha S. Sudenga SL, et al. Hum Immunol. 2013 Dec;74(12):1696-700. doi: 10.1016/j.humimm.2013.08.010. Epub 2013 Aug 21. Hum Immunol. 2013. PMID: 23973891 Free PMC article.

7

Role and uptake of human papillomavirus vaccine in adolescent health in the United States.

Sudenga SL, Royse KE, Shrestha S. Sudenga SL, et al. Adolesc Health Med Ther. 2011 Aug;2011(2):63-74. doi: 10.2147/AHMT.S15941. Adolesc Health Med Ther. 2011. PMID: 24155627 Free PMC article.

8

Dense genotyping of immune-related loci identifies variants associated with clearance of HPV among HIV-positive women in the HIV epidemiology research study (HERS).

Sudenga SL, Wiener HW, King CC, Rompalo AM, Cu-Uvin S, Klein RS, Shah KV, Sobel JD, Jamieson DJ, Shrestha S. Sudenga SL, et al. PLoS One. 2014 Jun 11;9(6):e99109. doi: 10.1371/journal.pone.0099109. eCollection 2014. PLoS One. 2014. PMID: 24918582 Free PMC article.

9

Alternative dosage schedules with HPV virus-like particle vaccines.

Stanley MA, Sudenga SL, Giuliano AR. Stanley MA, et al. Among authors: sudenga sl. Expert Rev Vaccines. 2014 Aug;13(8):1027-38. doi: 10.1586/14760584.2014.935767. Epub 2014 Jul 7. Expert Rev Vaccines. 2014. PMID: 25001893 Free PMC article. Review.

10

EUROGIN 2014 roadmap: differences in human papillomavirus infection natural history, transmission and human papillomavirus-related cancer incidence by gender and anatomic site of infection.

Giuliano AR, Nyitray AG, Kreimer AR, Pierce Campbell CM, Goodman MT, Sudenga SL, Monsonego J, Franceschi S. Giuliano AR, et al. Among authors: sudenga sl. Int J Cancer. 2015 Jun 15;136(12):2752-60. doi: 10.1002/ijc.29082. Epub 2014 Jul 26. Int J Cancer. 2015. PMID: 25043222 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

42 results

Search Page